Clinical Trials for Pericardial Disorders

Currently registered clinical trials for Pericardial Disorders from ClinicalTrials.gov. 9 recruiting, 50 total studies.

This content is for informational purposes only. Always consult a healthcare professional.

Source: ClinicalTrials.gov — U.S. National Library of Medicine — A database of privately and publicly funded clinical studies conducted around the world (U.S. National Library of Medicine, public domain).

This page lists clinical trials related to Pericardial Disorders from the ClinicalTrials.gov database.

Trial Summary

  • Total studies: 50
  • Recruiting: 9
  • Active, not recruiting: 3
  • Completed: 23
  • Other: 15

Results are refreshed periodically and may not reflect the most current information available from ClinicalTrials.gov.

Recruiting Trials

NCT04464655 — A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

StatusRecruiting
PhaseN/A
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment2130
Study TypeOBSERVATIONAL
ConditionsCoronary Artery Disease; Myocarditis; Infiltrative Cardiomyopathy; Dilated Cardiomyopathy; Hypertrophic Cardiomyopathy

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

NCT04843371 — PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

StatusRecruiting
PhaseN/A
SponsorTulane University
Enrollment500
Study TypeOBSERVATIONAL
ConditionsValvular Heart Disease; Pericardial Disease; Cardiomyopathies
Interventions

The investigators are aiming to investigate the association between ejection fraction (EF) determined by echocardiography and signals obtained from Photoplethysmography (PPG) in the general population. The investigators are also aiming to investigate the association between blood pressure and signals obtained from PPG in the general population.

Finally, the investigators are also aiming to inv…

NCT05777681 — Management of Aorto-iliac Infection With BioIntegral Surgical No-React® Bovine Pericardial Xenografts

StatusRecruiting
PhaseN/A
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment30
Study TypeOBSERVATIONAL
ConditionsAortic Diseases
Interventions

Aortic infections (AIs), including aortic graft infections (AGI) as well as mycotic aortic aneurysms (MAA), are rare. The aim of this study is to present our experience with xenogeneic aortic and aortoiliac reconstructions using the BioIntegral Surgical No-React® bovine pericardial graft.

NCT06388629 — Epicardial Access Study With Rook

StatusRecruiting
PhaseN/A
SponsorCirca Scientific, Inc.
Enrollment40
Study TypeINTERVENTIONAL
ConditionsArrythmia
Interventions

The goal of this clinical trial is to test how how effective the Circa Scientific Rook® Epicardial Access Kit is at gaining guidewire access to the outside surface of the heart (epicardium). In addition the safety of the device will be compared to the available data for alternative methods of epicardial access.

Participants will receive treatment with the subject device during the course of a …

NCT06063538 — Prevention of Postoperative Atrial Fibrillation (POAF) Using Intra-Pericardial Amiodarone

StatusRecruiting
PhaseEarly Phase 1
SponsorUniversity of Chicago
Enrollment63
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation; Post-Op Complication
Interventions

The purpose of this study is to evaluate the combination of CardiaMend, with the addition of amiodarone in the prevention of postoperative atrial fibrillation (POAF) in patients undergoing cardiac arterial bypass grafting (CABG) or valve surgery.

NCT07240441 — Endo-ePIcardial Versus Endocardial Only Catheter Ablation for ISchemic Driven Ventricular Tachycardia (EPISODE VT)

StatusRecruiting
PhaseN/A
SponsorMEDICOVER SP Z O.O.
Enrollment220
Study TypeINTERVENTIONAL
ConditionsVentricular Tachycardias; Myocardial Infarction (MI); Implantable Cardiac Defibrillator; Ablation
Interventions;

The EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2), who are protected by an implantable cardioverter-defibrilator (ICD) and meet study inclusion criteria.

NCT06800781 — Prolonged Chest Tube Treatment to Reduce Rates of Atrial Fibrillation Following Cardiac Surgery

StatusRecruiting
PhaseN/A
SponsorRegion Skane
Enrollment624
Study TypeINTERVENTIONAL
ConditionsCoronary Arterial Disease (CAD); Valve Replacement; Aortic Surgery
Interventions

Evacuation of pericardial blood by posterior pericardiotomy or use of a posterior pericardial chest tube lowers postoperative atrial fibrillation (POAF) rates after cardiac surgery by 45-68%. Although it cannot be generalized due to trial undersizing, posterior pericardial chest tube treatment may be a superior alternative to pericardiotomy, given its low risk of procedural complications.

This…

NCT07159269 — Cardiac point-of Care Ultrasound Training Pathway for Emergency Department Advanced Practice Providers

StatusRecruiting
PhaseN/A
SponsorDuke University
Enrollment75
Study TypeINTERVENTIONAL
ConditionsCardiovascular Disease Acute; Emergency Department Patient; Heart Failure Acute; Pulmonary Embolism (Diagnosis); Point of Care Ultrasound (POCUS)
Interventions

The aim of this study is to assess emergency medicine physician and advanced practice provider (APP) knowledge and technical skill in performance of a point-of-care ultrasound simulation and just-in-time training pathway to determine the feasibility, acceptability, and usability of the ultrasound training program. By performing this study, we hope to create a standardized training model which c…

NCT07669493 — Cardiac Safety Management and Immune Microenvironment Changes After Thoracic Radiotherapy: A Prospective Observational Study

StatusRecruiting
PhaseN/A
SponsorHebei Medical University Fourth Hospital
Enrollment150
Study TypeOBSERVATIONAL
ConditionsMACE, Arrhythmia, Pericardial Effusion and Survival

The goal of this observational study is to learn about cardiac safety monitoring after thoracic radiotherapy in adults with thoracic tumors.

The main question it aims to answer is:

Dose dynamic monitoring of cardiac biomarkers, electrocardiography, echocardiography, peripheral blood immune cell subsets, cytokines, chemokines, lipid profiles, and lipid metabolism markers help identify early cl…

Active, Not Recruiting

NCT02088554 — PERIGON Pivotal Trial

StatusActive, not recruiting
PhaseN/A
SponsorMedtronic Cardiac Surgery
Enrollment1312
Study TypeINTERVENTIONAL
ConditionsAortic Stenosis
Interventions

To evaluate the safety and effectiveness of the Model 400 aortic valve bioprosthesis.

NCT02732704 — THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

StatusActive, not recruiting
PhaseN/A
SponsorJenaValve Technology, Inc.
Enrollment100
Study TypeINTERVENTIONAL
ConditionsAortic Regurgitation
Interventions

To collect information about treatment for severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may include fatigue and shortness of breath. The preferred treatment for severe aortic regur…

NCT06972836 — Safety and Efficacy of Awake Uniportal Video Assisted Thoracoscopic Modified Pericardial Window in Recurrent Pericardial Effusion at Mid Term Result

StatusActive, not recruiting
PhaseN/A
SponsorZagazig University
Enrollment36
Study TypeINTERVENTIONAL
ConditionsAwake Thoracoscope; Pericardial Effusion; Pericadiopleural Window
Interventions;

this study compare two surgical techniues at the same time two methods of anathesia with assisstance of thoracoscope for cases of repeated collection of fluid in pericardial sac and observation the result of the two techniques on the operated patients from 3 to 6 months

Not Yet Recruiting

NCT06761872 — Predisposing Factors and Prevalence of Pericardial Diseases Among ESRD Patients Who Are Admitted in Critical Care Medicine Unit in Assuit University Hospital

StatusNot yet recruiting
PhaseN/A
SponsorAssiut University
Enrollment200
Study TypeOBSERVATIONAL
ConditionsPericardial Disease

The main objectives of this observational study are:

  1. Provide reliable data on the prevalence of pericardial diseases, pericardial effusion, constrictive pericarditis and its predisposing factors among ESRD patients, undergoing long-term dialysis.
  2. Detect the predisposing factors that could contribute to pericardial effusion amount and severity.

Participants (or their designated contact p…

NCT07194798 — Drainage Technique in CABG

StatusNot yet recruiting
PhaseN/A
SponsorAssiut University
Enrollment122
Study TypeOBSERVATIONAL
ConditionsCABG; Atrial Fibrillation (AF)

aims to compare the efficacy of the posterior pericardial window versus retro-cardiac drain in preventing postoperative atrial fibrillation and pericardial complications following CABG, while assessing their impact on hospital and ICU stay, pericardial effusions, re exploration for bleeding, post-operative blood transfusions, and mortality.

NCT07379112 — Safety and Performance of Dafodil Heart Valves in Real-World Aortic and Mitral Valve Replacement

StatusNot yet recruiting
PhaseN/A
SponsorMeril Life Sciences Pvt. Ltd.
Enrollment500
Study TypeOBSERVATIONAL
ConditionsAortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction; Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement
Interventions

This study, called the EuroDafodil Registry, is being conducted to understand how safe and effective the Dafodil™ and Dafodil Neo™ Pericardial Bioprosthetic heart valves are when used in routine medical practice.

The registry includes adult patients (18 years or older) who require surgical replacement of their aortic or mitral heart valve, either because their natural valve is severely disease…

NCT07245849 — Pericardial Imaging Study

StatusNot yet recruiting
PhasePhase 3
SponsorOttawa Heart Institute Research Corporation
Enrollment44
Study TypeINTERVENTIONAL
ConditionsPericarditis
Interventions

The pericardium is a thin, double-layered sac around the heart that helps reduce friction as the heart moves. When this sac gets inflamed, it is called pericarditis, which can cause serious health problems and even be life-threatening. Pericarditis often comes back after the first episode. About 10-30% of people will have it again, and half of those will have it multiple times. Although there a…

Enrolling by Invitation

NCT06293924 — Pericardial Fluid Analysis in Recurrent Pericarditis

StatusEnrolling by invitation
PhaseN/A
SponsorASST Fatebenefratelli Sacco
Enrollment432
Study TypeOBSERVATIONAL
ConditionsAcute Pericarditis; Pericardial Effusion; Pericardial Disease; Pericardial Fluid Exudate; Autoinflammatory Disorders
Interventions; ;

This clinical trial aims to examine the biochemical and cytological features of pericardial effusion during acute and recurrent pericarditis and to understand the molecular factors responsible for pathogenesis. The primary objective of this study is to identify and validate diagnostic criteria in pericardial fluid analysis that can differentiate patients with acute and recurrent pericarditis fr…

Completed Trials

NCT00347412 — Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

StatusCompleted
PhasePhase 3
SponsorCellectar Biosciences, Inc.
Enrollment903
Study TypeINTERVENTIONAL
ConditionsNon Small Cell Lung Cancer
Interventions; ;

The purpose of this clinical trial is to find out whether or not the combination of NOV-002 with chemotherapy (paclitaxel and carboplatin) is better at improving overall survival time when compared to chemotherapy alone in people with non-small cell lung cancer (NSCLC).

Earlier clinical trials in NSCLC showed that patients treated with NOV-002 in combination with chemotherapy had a better resp…

NCT00853632 — Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

StatusCompleted
PhaseN/A
SponsorEdwards Lifesciences
Enrollment329
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; Mitral Valve Regurgitation; Mitral Valve Incompetence; Heart Failure
Interventions

The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards® PERIMOUNT Magna Mitral Valves in patients undergoing mitral valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.

NCT01171625 — Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX

StatusCompleted
PhaseN/A
SponsorEdwards Lifesciences
Enrollment283
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; Aortic Valve Disorder; Heart Failure; Aortic Valve Stenosis; Aortic Valve Insufficiency
Interventions

The purpose of the study is to demonstrate the long term safety and effectiveness of the Carpentier-Edwards PERIMOUNT Magna Ease Valves in patients undergoing aortic valve replacement with or without concomitant procedures requiring cardiopulmonary bypass.

NCT01184183 — Trial Comparison of Accuseal and Bovine Pericardial Patch During Endarterectomy

StatusCompleted
PhaseN/A
SponsorCAMC Health System
Enrollment200
Study TypeOBSERVATIONAL
ConditionsCoronary Stenosis
Interventions

Carotid Endarterectomy (CEA), surgical removal of the blockage in the neck artery, is the accepted management of choice for significant blockage of the carotid artery. Previous studies showed improved perioperative outcomes and prevention of recurrent blockage by the use of the patch to close the surgical incision in the artery. The ideal patch reduces bleeding and prevents recurrent blockage.T…

NCT01757665 — ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)

StatusCompleted
PhaseN/A
SponsorEdwards Lifesciences
Enrollment777
Study TypeINTERVENTIONAL
ConditionsAortic Stenosis; Mitral Stenosis; Aortic Valve Insufficiency; Mitral Valve Insufficiency; Heart Failure
Interventions

The objective of this trial is to confirm that the modifications to tissue processing, valve sterilization and packaging do not raise any new questions of safety and effectiveness in subjects who require replacement of their native or prosthetic aortic or mitral valve.

NCT02073331 — Obtain Additional Information on Use of CorMatrix ECM (Extracellular Matrix)

StatusCompleted
PhaseN/A
SponsorElutia Inc.
Enrollment1420
Study TypeOBSERVATIONAL
ConditionsCoronary Disease

The objective of the study is to actively gather additional information on the use of CorMatrix ECM for pericardial reconstruction.

NCT06584370 — Transatrial Pericardial Separation to Enhance Safety of Subxiphoid Pericardial Access for Left Atrial Appendage Ligation

StatusCompleted
PhaseN/A
SponsorHenry Ford Health System
Enrollment13
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation; Left Atrial Appendage Ligation; Pericardium; Epicardial Mapping; Heart Atria
Interventions

We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.

NCT02260206 — Impact of Colchicine Therapy on Arrhythmia Recurrence After Acute Pericardial Effusion

StatusCompleted
PhasePhase 4
SponsorYong Seog Oh
Enrollment20
Study TypeINTERVENTIONAL
ConditionsPericardial Effusion
Interventions

The effects colchicine administration for acute pericardial effusion after radiofrequency catheter ablation (RFCA) of atrial fibrillation on the recurrences of arrhythmia.

NCT02399384 — Pericardial Fat and Inflammation in HIV Patients and Controls

StatusCompleted
PhaseN/A
SponsorUniversity of Cincinnati
Enrollment12
Study TypeOBSERVATIONAL
ConditionsCoronary Artery Disease; Human Immunodeficiency Virus (HIV)

The investigators propose to correlate 1) cardiac MRI pericardial adipose volume, 2) the presence of pericardial monocytes and 3) circulating immune biomarkers in persons with and without CHD and HIV infection compared to seronegative controls with known CHD. The investigators aim to test the hypothesis that higher amounts of pericardial fat deposition and increased presence of monocytes within…

NCT02808897 — Active Clearance of Chest Tubes After Cardiac Surgery: A Prospective Randomized Controlled Study

StatusCompleted
PhaseN/A
SponsorMontreal Heart Institute
Enrollment520
Study TypeINTERVENTIONAL
ConditionsAtrial Fibrillation; Pericardial Effusion; Pleural Effusion; Hemothorax; Cardiac Tamponade
Interventions;

The purpose of this study is to assess the effectiveness of the PleuraFlow® Active Tube Clearance (ATC) technology in reducing the rate of postoperative atrial fibrillation (POAF) among post cardiac surgery patients and to evaluate the impact of Active Tube Clearance (ATC) on other complications, such as retained blood syndrome (RBS), a composite endpoint including re-exploration for bleeding o…

NCT02656290 — COMMENCE Pulmonary: Clinical Evaluation of Edwards Pericardial Aortic Bioprosthesis (Model 11000A) for Pulmonary Valve Replacement

StatusCompleted
PhaseN/A
SponsorEdwards Lifesciences
Enrollment26
Study TypeINTERVENTIONAL
ConditionsPulmonary Valve Insufficiency; Pulmonary Valve Degeneration; Congenital Pulmonary Valve Abnormality
Interventions

The objective of this trial is to assess the safety and effectiveness of the Edwards Pericardial Aortic Bioprosthesis Model 11000A, in the pulmonary position in pediatric and adult subjects five years or older requiring replacement of their native or prosthetic pulmonary valve.

NCT05061914 — Surgical Options for Management of Pericardial Effusion

StatusCompleted
PhaseN/A
SponsorSohag University
Enrollment60
Study TypeINTERVENTIONAL
ConditionsPericardial Effusion
Interventions

This is a retrospective descriptive study which will be conducted at Sohag university Hospital, Sohag, Egypt at emergency and cardiothoracic department . It includes all patients with pericardial effusion who diagnosed as temponading pericardial effusion or threatened cardiac temponade , The aim of this work is to clarify the suitability and individualization of each surgical procedure (either …

NCT02965625 — Characterization of Epicardial and Pericardial Adipose Tissue in Coronary Artery Disease

StatusCompleted
PhaseN/A
SponsorRigshospitalet, Denmark
Enrollment28
Study TypeOBSERVATIONAL
ConditionsCoronary Artery Disease

Human epicardial fat is the true visceral fat depot of the heart, and its regional distribution and physiology is of growing scientific and clinical interest. This study aims to characterize the expression profile and function of the epicardial and pericardial adipose tissue compartments of the heart (EAT and PAT). EAT and PAT adipose biopsies will be obtained from patients undergoing coronary …

NCT03327688 — Point-of-care Ultrasound in Finland

StatusCompleted
PhaseN/A
SponsorOssi Hannula
Enrollment220
Study TypeINTERVENTIONAL
ConditionsDeep Vein Thrombosis; Abdominal Aortic Aneurism; Pneumothorax; Gallbladder Diseases; Hydronephrosis
Interventions

This study has two aims.

  1. Deep venous thrombosis (DVT) is a common suspected medical condition. If it cannot be excluded clinically and using D-dimer, ultrasound examination is required. An option for traditional radiologist-performed ultrasound is a 2-point compression ultrasound (2-CUS). The safety of this technique is proven. However there does not exist any data on costs comparing tradit…

NCT03796442 — Comparison of Two Pericardial Bioprostheses in AVR

StatusCompleted
PhaseN/A
SponsorSeoul National University Hospital
Enrollment140
Study TypeINTERVENTIONAL
ConditionsAortic Valve Disease
Interventions;

The purpose of the study is to compare early and 1-year hemodynamic performance and clinical outcomes after aortic valve replacement using two pericardial bioprosthesis, Avalus and Carpentier Edwards Perimount Magna Ease.

NCT03887286 — Focused Cardiac Ultrasound

StatusCompleted
PhaseN/A
SponsorUniversity of Miami
Enrollment47
Study TypeINTERVENTIONAL
ConditionsVentricular Dysfunction; Pericardial Effusion; Valvular Disease; Septal Defect
Interventions;

To compare the images from standard cardiac ultrasound with images from a small hand-held device; to find out more about the feasibility and accuracy of a small hand-held ultrasound device.

NCT03798353 — Pericardial Matrix With Mesenchymal Stem Cells for the Treatment of Patients With Infarcted Myocardial Tissue

StatusCompleted
PhasePhase 1
SponsorFundació Institut Germans Trias i Pujol
Enrollment12
Study TypeINTERVENTIONAL
ConditionsMyocardial Infarction
Interventions;

Myocardial infarction causes necrosis of myocardial cells and reduces cardiac function. Today, there are treatments such as primary angioplasty and thrombolysis that are effective in limiting cell death after acute myocardial infarction. However, the post-infarct scar often conditions a global ventricular remodeling that can evolve clinically towards heart failure and in more advanced stages th…

NCT04816851 — Aortic Valve Leaflets Reconstruction (Ozaki Procedure) in Aortic Valve Diseases

StatusCompleted
PhaseN/A
SponsorAssiut University
Enrollment1
Study TypeOBSERVATIONAL
ConditionsAortic Valve Disease
Interventions

Prospective Cohort Study aims at elaborating the outcomes of the Tricuspid Reconstruction of Aortic valve leaflets using autologous pericardium (Ozaki procedure) in the adult and paediatric patients. A very promising technique with the potential benefits of dodging oral anticoagulation, foreign material, and suitable for patients with small aortic annuli and in infectious endocarditis.

Perform…

NCT05383456 — The Visceral Adiposity Measurement and Observation Study

StatusCompleted
PhaseN/A
SponsorTheratechnologies
Enrollment196
Study TypeOBSERVATIONAL
ConditionsHIV; HIV-Infections; HIV-1-infection; HIV I Infection; HIV Lipodystrophy
Interventions;

The Visceral Adiposity Measurement and Observation Study

NCT06952179 — Pericardial Histopathology and COVID-19 Seropositivity

StatusCompleted
PhaseN/A
SponsorSamsun University
Enrollment93
Study TypeOBSERVATIONAL
ConditionsInflammatory Response; COVID-19; Pericardial Disease

This prospective study aims to investigate the association between pericardial histopathologic inflammation grades (acute, chronic, or absent) and COVID-19 seropositivity in adult patients undergoing first-time isolated coronary artery bypass grafting (CABG). Pericardial tissue samples were collected during surgery and evaluated histopathologically, while preoperative COVID-19 serological testi…

NCT06088680 — Post Market Observational Retrospective Study of Glycar Bovine Pericardial Patch (CIP-003)

StatusCompleted
PhaseN/A
SponsorGLYCAR SA (Pty) Ltd
Enrollment50
Study TypeOBSERVATIONAL
ConditionsCardiac Defect; Cardiac Anomaly; Pericardial Defect
Interventions

The overall purpose of this observational Post Market Clinical Follow Up (PMCF) study is to ensure continued acceptability of the benefit risk ratio by assessment of safety and performance, in patients undergoing cardiovascular repair or reconstruction surgery under standard clinical care with the commercially available Glycar Pericardial Patch.

NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF

StatusCompleted
PhaseN/A
SponsorSeoul National University Hospital
Enrollment270
Study TypeINTERVENTIONAL
ConditionsCoronary Artery Disease; Atrial Fibrillation New Onset; Pericardial Effusion
Interventions

This study is planned to evaluate the effect of left posterior pericardiotomy for the prevention of postoperative atrial fibrillation after coronary artery bypass grafting. Eligible patients will be randomized to be created or not to be created the left posterior pericardiotomy at the end of the operation, and the incidence of postoperative atrial fibrillation will be compared.

NCT06959836 — Post-market Safety and Performance Outcomes of the VIVERE® Bovine Pericardial Bioprosthetic Valve

StatusCompleted
PhaseN/A
SponsorBraile Biomedica Ind. Com. e Repr. Ltda.
Enrollment150
Study TypeOBSERVATIONAL
ConditionsAORTIC VALVE DISEASES; Aortic Valve Stenosis and Insufficiency; Aortic Valve Surgery; Mitral Valve Regurgitation; Mitral Valve Surgery
Interventions

This study aims to collect post-market safety and performance data related to the procedure and follow-up of the VIVERE Bovine Pericardial Bioprosthetic Valve, when used in accordance with the product’s Instructions for Use (IFU).

Other (Terminated)

NCT00791154 — QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer

StatusTerminated
PhasePhase 1 / Phase 2
SponsorNantCell, Inc.
Enrollment213
Study TypeINTERVENTIONAL
ConditionsLung Cancer; Small Cell Lung Cancer; Solid Tumors; Extensive-stage Small Cell Lung Cancer
Interventions; ;

This trial is titled “A Phase 1b/2 trial of AMG 479 or AMG 102 with Platinum-Based Chemotherapy as First-Line Treatment for Extensive Stage Small-Cell Lung Cancer (SCLC).”

Part 1, the phase 1b portion of this study, is a multicenter, open-label investigation to identify safe dose levels of either AMG 102 or AMG 479 in combination with etoposide plus cisplatin or carboplatin in subjects with pr…

NCT02351726 — Mitroflow DL Post Approval Study- North America

StatusTerminated
PhaseN/A
SponsorLivaNova
Enrollment186
Study TypeINTERVENTIONAL
ConditionsAortic Stenosis; Aortic Regurgitation; Aortic Valve Insufficiency; Heart Valve Diseases; Cardiovascular Abnormalities
Interventions

Prospective, non-randomized, multicenter post-approval study to collect long term clinical and echographic data on Mitroflow DL patients.

NCT02132884 — Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

StatusTerminated
PhaseN/A
SponsorFox Chase Cancer Center
Enrollment1
Study TypeINTERVENTIONAL
ConditionsMalignant Pericardial Effusion; Malignant Pleural Effusion; Recurrent Non-small Cell Lung Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IV Non-small Cell Lung Cancer
Interventions; ;

This randomized clinical trial studies how well genetic sequencing-informed targeted therapy works in treating patients with stage IIIB-IV non-small cell lung cancer. Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific types of tumor cells that may have less harm to normal cells. Genetic sequencing may help identify these specific types of…

Other (Unknown)

NCT02732691 — JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study

StatusUnknown
PhaseN/A
SponsorJenaValve Technology, Inc.
Enrollment68
Study TypeINTERVENTIONAL
ConditionsAortic Valve Stenosis; Heart Valve Diseases; Heart Diseases; Cardiovascular Diseases; Ventricular Outflow Obstruction
Interventions

To collect information about treatment for severe aortic stenosis (AS), which affects the aortic valve in the heart. Aortic stenosis is a narrowing of the aortic valve opening, which decreases blood flow from the heart and causes symptoms such as chest pain, fainting and shortness of breath. The preferred treatment for severe aortic stenosis is aortic valve replacement surgery.

NCT04472468 — Primary Percutaneous Pericardiotomy for Malignant Pericardial Effusion (PMAP)

StatusTerminated
PhaseN/A
SponsorChinese University of Hong Kong
Enrollment50
Study TypeINTERVENTIONAL
ConditionsPericardial Effusion Malignant
Interventions

Pericardial effusion is a common complication in patients with metastatic malignancy. While pericardiocentesis provide effective relieve from life-threatening situation such as cardiac tamponade, recurrence of pericardial effusion after pericardiocentesis is common. We hypothesize that percutaneous balloon pericardiotomy in addition to standard pericardiocentesis with prolonged drainage can pre…

NCT05077111 — A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia

StatusUnknown
PhasePhase 4
SponsorMohamed Reda Ashour
Enrollment40
Study TypeINTERVENTIONAL
ConditionsPleural Effusion, Malignant; Pleural Mesothelioma; Pleural Empyema; Pulmonary Diseases or Conditions; Pleural Neoplasms
Interventions;

Video-assisted thoracic surgery (VATS) is usually performed with general anesthesia and single lung ventilation. However, performing thoracic surgery under awake regional anesthesia has several potential advantages including avoidance of airway trauma and ventilator dependence associated with endotracheal intubation, besides promoting enhanced recovery after surgery and shorter mean hospital stay.

NCT04279327 — Cell Block Immunohistochemistry in Effusion Cytology

StatusUnknown
PhaseN/A
SponsorAssiut University
Enrollment100
Study TypeOBSERVATIONAL
ConditionsEffusion Pleural; Ascites; Pericardial Effusion

Cytology is usually the first step in investigating serous effusions, to either detect or exclude an underlying malignancy. This study will try to answer the need for improved diagnostic yield of cytologic examination by cell block technique and immunohistochemical testing of three markers which are EZH2, Claudin-4 and MOC-31.

NCT05146492 — Pericardial Effusion From Acute Myocardial Infarction: Contributing Factors and Prognosis at One Year (EPERICARDIM)

StatusTerminated
PhaseN/A
SponsorRamsay Générale de Santé
Enrollment3
Study TypeINTERVENTIONAL
ConditionsAcute Myocardial Infarction; Pericardial Effusion
Interventions

This study aims to clarify, in patients with more or less abundant pericardial effusion in the acute phase of a myocardial infarction, the correlation between the existence of this effusion during the acute phase with clinical parameters, biological, angiographic, therapeutic and with transmurality, extent, microvascular obstruction and intra myocardial hemorrhage found on MRI made beyond one w…

NCT05308589 — CPPF After General Cardiac Surgery

StatusTerminated
PhaseN/A
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment164
Study TypeINTERVENTIONAL
ConditionsCardiac Surgical Procedures; Retained Blood Syndrome; Cardiac Tamponade; Postoperative Hemorrhage
Interventions

In two randomized clinical trials the investigators have demonstrated that continuous postoperative pericardial flushing (CPPF) therapy can reduce postoperative blood loss and bleeding-related complications after cardiac surgery and that CPPF therapy is safe and feasible in an experimental setting. The Haermonics investigational device is a novel medical device that enables CPPF therapy to be u…

Other (Suspended)

NCT06479824 — NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study

StatusSuspended
PhaseN/A
SponsorNational Heart, Lung, and Blood Institute (NHLBI)
Enrollment60
Study TypeINTERVENTIONAL
ConditionsTricuspid Valve Insufficiency
Interventions

Background:

Tricuspid valve regurgitation is a disease where one of the heart valves leaks. The leak affects blood flow. People with this disease may feel breathless and lack energy; they may need to stay in the hospital when fluid builds up in the body. The tricuspid is the most difficult valve to repair with surgery. Researchers want to try a new procedure called trans-atrial intra-pericardi…